A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Vaccine
; 34(11): 1412-21, 2016 Mar 08.
Article
en En
| MEDLINE
| ID: mdl-26854906
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Tuberculosis
/
Vacunas contra la Tuberculosis
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Vaccine
Año:
2016
Tipo del documento:
Article
País de afiliación:
Reino Unido